Aimee Mcrae-Clark to Double-Blind Method
This is a "connection" page, showing publications Aimee Mcrae-Clark has written about Double-Blind Method.
Connection Strength
1.867
-
Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial. Drug Alcohol Depend. 2021 12 01; 229(Pt B):109111.
Score: 0.147
-
The effect of oxytocin, gender, and ovarian hormones on stress reactivity in individuals with cocaine use disorder. Psychopharmacology (Berl). 2020 Jul; 237(7):2031-2042.
Score: 0.134
-
Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. Drug Alcohol Depend. 2018 06 01; 187:270-277.
Score: 0.116
-
Approach bias modification for cannabis use disorder: A proof-of-principle study. J Subst Abuse Treat. 2018 04; 87:16-22.
Score: 0.114
-
Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women. Pharmacol Biochem Behav. 2018 02; 165:63-69.
Score: 0.112
-
Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
Score: 0.110
-
Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women. Addict Behav. 2016 09; 60:197-202.
Score: 0.101
-
Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75.
Score: 0.099
-
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37.
Score: 0.096
-
Impact of acute guanfacine administration on stress and cue reactivity in cocaine-dependent individuals. Am J Drug Alcohol Abuse. 2015 Mar; 41(2):146-52.
Score: 0.090
-
Effect of oxytocin on craving and stress response in marijuana-dependent individuals: a pilot study. Psychopharmacology (Berl). 2013 Aug; 228(4):623-31.
Score: 0.082
-
A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
Score: 0.068
-
A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
Score: 0.064
-
Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
Score: 0.055
-
A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
Score: 0.043
-
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
Score: 0.043
-
Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. Psychol Addict Behav. 2022 Aug; 36(5):505-514.
Score: 0.036
-
Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women. Drug Alcohol Depend. 2021 01 01; 218:108383.
Score: 0.034
-
Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
Score: 0.032
-
Cortisol reactivity and situational drug use in cocaine-dependent females. Psychiatry Res. 2019 12; 282:112611.
Score: 0.032
-
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
Score: 0.027
-
Effects of yohimbine and drug cues on impulsivity and attention in cocaine-dependent men and women and sex-matched controls. Drug Alcohol Depend. 2016 May 01; 162:56-63.
Score: 0.025
-
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82.
Score: 0.025
-
Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence. Psychiatry Res. 2015 Sep 30; 229(1-2):94-100.
Score: 0.024
-
D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. Am J Addict. 2015 Apr; 24(3):217-224.
Score: 0.023
-
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
Score: 0.022
-
Yohimbine administration and cue-reactivity in cocaine-dependent individuals. Psychopharmacology (Berl). 2014 Oct; 231(21):4157-65.
Score: 0.022
-
Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):195-201.
Score: 0.020
-
A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans. Psychopharmacology (Berl). 2013 Apr; 226(4):721-37.
Score: 0.020
-
A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012 Aug; 169(8):805-12.
Score: 0.019
-
A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on craving in cocaine-dependent individuals. Psychopharmacology (Berl). 2013 Apr; 226(4):739-46.
Score: 0.019
-
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
Score: 0.012